Hereditary paraganglioma-pheochromocytoma syndromes associated with SDHD and RET mutations

被引:3
作者
Choi, Joseph Do Woong [1 ]
Tucker, Katherine M. [2 ]
Lee, Tack Tsiew [1 ]
Chong, Guan C. [1 ]
机构
[1] Australian Natl Univ, Sch Med, Canberra Hosp, Acad Surg Unit, Canberra, ACT 2601, Australia
[2] Prince Wales Hosp, Hereditary Canc Serv, Randwick, NSW 2031, Australia
来源
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2014年 / 36卷 / 10期
关键词
paraganglioma; pheochromocytoma; hereditary; succinate dehydrogenase subunit D (SDHD) mutation; rearranged during transfection (RET) mutation; ENDOCRINE NEOPLASIA TYPE-2; GENETICS; HEAD;
D O I
10.1002/hed.23598
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background. Hereditary paraganglioma-pheochromocytoma syndromes (PGL/PCC) are rare tumors arising from neuroendocrine cells. Methods and Results. The proband, a 59-year-old white man and his 42-year-old elder son had a medical history of bilateral carotid body PGL and both presented for treatment of abdominal PGLs. His 36-year-old daughter had excision of recurrent malignant carotid body PGL and vertebral metastasis. His 33-year-old youngest son presented for excision of a unilateral carotid body PGL. All 4 members had succinate dehydrogenase subunit D (SDHD) mutations, whereas the proband and youngest son also had concurrent rearranged during transfection (RET) mutation. Conclusion. This is the first report of PGL/PCC with SDHD and RET mutations. The role of the RET gene as a modifier remains speculative. Additionally, the family pedigree suggests maternal inheritance of disease from the probands' paternal grandmother. Clinicians should refer PGL/PCC families for mutation analysis as well as being alert to changes in the classification of mutations. (C) 2014 Wiley Periodicals, Inc.
引用
收藏
页码:E99 / E102
页数:4
相关论文
共 20 条
  • [1] The genetics of paragangliomas
    Burnichon, N.
    Abermil, N.
    Buffet, A.
    Favier, J.
    Gimenez-Roqueplo, A. -P.
    [J]. EUROPEAN ANNALS OF OTORHINOLARYNGOLOGY-HEAD AND NECK DISEASES, 2012, 129 (06) : 315 - 318
  • [2] CHONG GC, 1975, CANCER, V35, P695, DOI 10.1002/1097-0142(197503)35:3<695::AID-CNCR2820350323>3.0.CO
  • [3] 2-W
  • [4] Extra-adrenal pheochromocytoma involving the organ of Zuckerkandl
    Donahue, James
    Sahani, Dushyant
    Tso, Li
    Cusack, James C., Jr.
    [J]. SURGERY, 2008, 143 (06) : 830 - 832
  • [5] Erdogan B A, 2012, Prague Med Rep, V113, P262
  • [6] Pathogenicity of DNA Variants and Double Mutations in Multiple Endocrine Neoplasia Type 2 and Von Hippel-Lindau Syndrome
    Erlic, Zoran
    Hoffmann, Michael M.
    Sullivan, Maren
    Franke, Gerlind
    Peczkowska, Mariola
    Harsch, Igor
    Schott, Matthias
    Gabbert, Helmut E.
    Valimaki, Matti
    Preuss, Simon F.
    Hasse-Lazar, Kornelia
    Waligorski, Dariusz
    Robledo, Mercedes
    Januszewicz, Andrzej
    Eng, Charis
    Neumann, Hartmut P. H.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (01) : 308 - 313
  • [7] External Beam Radiation Therapy (EBRT) for Patients with Malignant Pheochromocytoma and Non-Head and -Neck Paraganglioma: Combination with 131I-MIBG
    Fishbein, L.
    Bonner, L.
    Torigian, D. A.
    Nathanson, K. L.
    Cohen, D. L.
    Pryma, D.
    Cengel, K. A.
    [J]. HORMONE AND METABOLIC RESEARCH, 2012, 44 (05) : 405 - 410
  • [8] Genetics and molecular pathogenesis of pheochromocytoma and paraganglioma
    Galan, S. R.
    Kann, P. H.
    [J]. CLINICAL ENDOCRINOLOGY, 2013, 78 (02) : 165 - 175
  • [9] Kapoor Nitin, 2012, Endocr Pract, V18, pe106, DOI 10.4158/EP12012.CR
  • [10] Kirmani S, 2012, GENE REV